ATSE:BIOSK

Stock Analysis Report

Executive Summary

Unibios Holdings S.A., through its subsidiaries, develops and installs water treatment systems in Europe.

Snowflake

Fundamentals

Imperfect balance sheet and overvalued.

Share Price & News

How has Unibios Holdings's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

8.0%

BIOSK

3.8%

GR Machinery

1.7%

GR Market


1 Year Return

26.4%

BIOSK

4.1%

GR Machinery

34.1%

GR Market

Return vs Industry: BIOSK exceeded the Greek Machinery industry which returned 4.1% over the past year.

Return vs Market: BIOSK underperformed the Greek Market which returned 34.1% over the past year.


Shareholder returns

BIOSKIndustryMarket
7 Day8.0%3.8%1.7%
30 Day19.8%0.6%0.08%
90 Day12.7%0.1%1.8%
1 Year48.9%26.4%7.6%4.1%38.7%34.1%
3 Year-6.4%-20.6%25.6%12.7%63.6%48.3%
5 Year-49.3%-57.0%62.5%37.5%-78.3%-78.8%

Price Volatility Vs. Market

How volatile is Unibios Holdings's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Unibios Holdings undervalued compared to its fair value and its price relative to the market?

0.13x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate BIOSK's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate BIOSK's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: BIOSK is unprofitable, so we can't compare its PE Ratio to the Machinery industry average.

PE vs Market: BIOSK is unprofitable, so we can't compare its PE Ratio to the Greek market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate BIOSK's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: BIOSK is good value based on its PB Ratio (0.1x) compared to the XE Machinery industry average (1.6x).


Next Steps

Future Growth

How is Unibios Holdings forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

9.5%

Forecasted Capital Goods industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Unibios Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Unibios Holdings performed over the past 5 years?

1.7%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: BIOSK is unprofitable, but has reduced losses over the past 5 years at a rate of 1.7% per year.

Accelerating Growth: Unable to compare BIOSK's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: BIOSK is unprofitable, making it difficult to compare its past year earnings growth to the Machinery industry (4.3%).


Return on Equity

High ROE: BIOSK has a negative Return on Equity (-2.48%), as it is currently unprofitable.


Return on Assets

ROA vs Industry: BIOSK is currently unprofitable, so its Return on Assets is negative.


Return on Capital Employed

ROCE Improving: BIOSK is currently unprofitable, so its Return on Capital Employed is negative.


Next Steps

Financial Health

How is Unibios Holdings's financial position?


Financial Position Analysis

Short Term Liabilities: BIOSK's short term assets (€8.1M) do not cover its short term liabilities (€8.2M)

Long Term Liabilities: BIOSK's short term assets (8.1M) exceeds its long term liabilities (4.1M)


Debt to Equity History and Analysis

Debt Level: BIOSK's debt to equity ratio (28.5%) is considered satisfactory

Reducing Debt: BIOSK's debt to equity ratio has increased from 13.9% to 28.5% over the past 5 years.


Balance Sheet

Inventory Level: BIOSK has a high level of physical assets or inventory.

Debt Coverage by Assets: BIOSK's debt is covered by short term assets (assets are 2.862900x debt).


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: BIOSK has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: BIOSK has less than a year of cash runway if free cash flow continues to reduce at historical rates of -27.4% each year


Next Steps

Dividend

What is Unibios Holdings's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%1.8%markettop25%3.6%industryaverage3.0%forecastin3Yearsn/a

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: Unable to evaluate BIOSK's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate BIOSK's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.

Stable Dividend: Insufficient data to determine if BIOSK's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if BIOSK's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of BIOSK's dividend in 3 years as they are not forecast to pay a notable one for the Greek market.


Next Steps

Management

What is the CEO of Unibios Holdings's salary, the management and board of directors tenure and is there insider trading?


CEO

Nik Mavrikios 0

0yrs

Tenure

0

Mr. Orfeas Nikolau Mavrikios, also known as Nik, serves as Chief Executive Officer, Vice Chairman and Managing Director at Unibios Holdings S.A. He holds Bachelor's degree in Economics at Hamilton College  ...


Insider Trading

Insider Buying: BIOSK insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Buy€846,55518 Sep 19
Antonios Svoronos
EntityIndividual
Role
Chairman of the Board
Chairman
Shares2,821,852
Max Price€0.30
Sell€24,15002 Aug 19
Antonios Svoronos
EntityIndividual
Role
Chairman of the Board
Chairman
Shares154,500
Max Price€0.39
Buy€26,18102 Aug 19
Antonios Svoronos
EntityIndividual
Role
Chairman of the Board
Chairman
Shares173,669
Max Price€0.39
Sell€6,00030 Jul 19
Antonios Svoronos
EntityIndividual
Role
Chairman of the Board
Chairman
Shares40,000
Max Price€0.15
Sell€10,23830 Jan 19
Antonios Svoronos
EntityIndividual
Role
Chairman of the Board
Chairman
Shares31,023
Max Price€0.33

Ownership Breakdown


Management Team

  • Antony Svoronos (58yo)

    Chairman

    • Tenure: 0yrs
  • Nik Mavrikios

    Vice-Chairman

    • Tenure: 0yrs
  • Anastasios Theodorakopoulos

    Executive Director

    • Tenure: 0yrs
  • George Bekos

    Group CFO & Executive Director

    • Tenure: 0yrs
  • Ilias Giannakopoulos

    Executive Director

    • Tenure: 0yrs

Board Members

  • Antony Svoronos (58yo)

    Chairman

    • Tenure: 0yrs
  • Nik Mavrikios

    Vice-Chairman

    • Tenure: 0yrs
  • Anastasios Theodorakopoulos

    Executive Director

    • Tenure: 0yrs
  • George Bekos

    Group CFO & Executive Director

    • Tenure: 0yrs
  • Nikolaos Travlos

    Independent Non-Executive Director

    • Tenure: 0yrs
  • Ioannis Methodios

    Independent Non-Executive Director

    • Tenure: 0yrs
  • Rigas-Alexandros Karavias

    Independent Non-Executive Director

    • Tenure: 0yrs
  • Alexandros Kalogirou

    Independent Non-Executive Director

    • Tenure: 0yrs
  • Ilias Giannakopoulos

    Executive Director

    • Tenure: 0yrs
  • Georgios Papathanasiou

    Independent Non Executive Director

    • Tenure: 0yrs

Company Information

Unibios Holdings S.A.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Unibios Holdings S.A.
  • Ticker: BIOSK
  • Exchange: ATSE
  • Founded: 1940
  • Industry: Industrial Machinery
  • Sector: Capital Goods
  • Market Cap: €1.295m
  • Shares outstanding: 3.10m
  • Website: https://www.unibios.gr

Location

  • Unibios Holdings S.A.
  • 1st and 18th Street
  • Ano Liosia
  • 133 41
  • Greece

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
BIOSKATSE (The Athens Stock Exchange)YesOrdinary SharesGREURJul 1993

Biography

Unibios Holdings S.A., through its subsidiaries, develops and installs water treatment systems in Europe. It also distributes products and systems for the heating and air conditioning of buildings. Unibios ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/21 20:45
End of Day Share Price2019/10/21 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.